Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

E.U. approval for Exjade

Aug. 30, 2006

Antidote for isotope intoxication reported by Department of Atomic Energy in India

Aug. 8, 2006

Chantix now available in U.S.

Aug. 2, 2006

Protectan CBLB-502 demonstrates effectiveness in ARS in primates

Aug. 2, 2006

Champix recommended for approval in Europe

July 31, 2006

Suboxone receives approval recommendation in Europe

July 31, 2006

Oral nalmefene demonstrates positive results in pilot smoking cessation study

July 28, 2006

European CHMP hands down positive opinion for Exjade

July 5, 2006

Valera seeks to begin clinical studies of VP-004 naltrexone implant

June 29, 2006

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

June 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...